Teva and Allergan reach another opioid settlement, this time for $54M with San Francisco
Another settlement in the litigation of the opioid crisis has been reached.
According to David Chiu, San Francisco’s city attorney, the city reached a combined $54 million settlement agreement against both Teva and AbbVie’s Allergan on Wednesday. Under the agreement in principle, opioid manufacturers Allergan and Teva will pay San Francisco $34 million in cash payments.
According to a statement from Teva, the manufacturer is providing $24.8 million over 13 years from their end as well as $20 million worth of Narcan over the next 10 years. AbbVie’s Allergan was not immediately available for comment.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.